{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:26:21Z","timestamp":1791584781497,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.thromres.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T06:56:19Z","timestamp":1715324179000},"page":"109036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Anticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients"],"prefix":"10.1016","volume":"239","author":[{"given":"Tony","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chipman Taylor","family":"Drury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl","key":"10.1016\/j.thromres.2024.05.009_bb0005","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.thromres.2024.05.009_bb0010","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2024.05.009_bb0015","series-title":"Venous thromboembolism in over 16s: Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism","author":"National Institute for Health and Care Excellence (NICE)","year":"2018"},{"issue":"24","key":"10.1016\/j.thromres.2024.05.009_bb0020","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1161\/CIR.0000000000000769","article-title":"Call to action to prevent venous thromboembolism in hospitalized patients: a policy statement from the American Heart Association","volume":"141","author":"Henke","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2024.05.009_bb0025","series-title":"QMENTUM PROGRAM STANDARDS Inpatient Services","author":"Accreditation Canada","year":"2021"},{"issue":"6","key":"10.1016\/j.thromres.2024.05.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102184","article-title":"Overuse and underuse of thromboprophylaxis in medical inpatients","volume":"7","author":"Kocher","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2024.05.009_bb0035","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamainternmed.2018.2022","article-title":"Use of venous thromboembolism prophylaxis in hospitalized patients","volume":"178","author":"Grant","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2024.05.009_bb0040","article-title":"Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)","volume":"2014","author":"Alikhan","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.thromres.2024.05.009_bb0045","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1182\/blood-2011-11-376293","article-title":"How I treat heparin-induced thrombocytopenia","volume":"119","author":"Cuker","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2024.05.009_bb0050","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2024.05.009_bb0055","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thromres.2024.05.009_bb0060","article-title":"Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity","volume":"2021","author":"Mohammady","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.thromres.2024.05.009_bb0065","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2352-3026(22)00171-5","article-title":"Counting the carbon cost of heparin: an evolving tragedy of the commons?","volume":"9","author":"Fan","year":"2022","journal-title":"Lancet Haematol."},{"issue":"2","key":"10.1016\/j.thromres.2024.05.009_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jth.14372","article-title":"Imminent risk of a global shortage of heparin caused by the African swine fever afflicting the Chinese pig herd","volume":"17","author":"Vilanova","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2024.05.009_bb0075","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/molecules22061025","article-title":"From farm to pharma: an overview of industrial heparin manufacturing methods","volume":"22","author":"der Meer","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.thromres.2024.05.009_bb0080","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.10-1944","article-title":"Predictive and associative models to identify hospitalized medical patients at risk for VTE","volume":"140","author":"Spyropoulos","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.thromres.2024.05.009_bb0085","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11096-019-00834-2","article-title":"The effect of hospital-based antithrombotic stewardship on adherence to anticoagulant guidelines","volume":"41","author":"Dreijer","year":"2019","journal-title":"Int. J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.thromres.2024.05.009_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235048","article-title":"Effect of antithrombotic stewardship on the efficacy andsafety of antithrombotic therapy during and after hospitalization","volume":"15","author":"Dreijer","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.thromres.2024.05.009_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12758","article-title":"Anticoagulation stewardship: descriptive analysis of a novel approach to appropriate anticoagulant prescription","volume":"6","author":"Koolian","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2024.05.009_bb0100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11239-016-1455-z","article-title":"The scope and value of an anticoagulation stewardship program at a community teaching hospital","volume":"43","author":"Wychowski","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"issue":"11","key":"10.1016\/j.thromres.2024.05.009_bb0105","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.05.009_bb0110","series-title":"ARECCI Ethics Guideline Tool","author":"Alberta Innovates","year":"2017"},{"issue":"8","key":"10.1016\/j.thromres.2024.05.009_bb0115","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200332","article-title":"Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patients","volume":"2","author":"Mottier","year":"2023","journal-title":"NEJM Evid."},{"issue":"16","key":"10.1016\/j.thromres.2024.05.009_bb0120","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2015-07-660001","article-title":"Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program","volume":"127","author":"McGowan","year":"2016","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T04:44:24Z","timestamp":1717562664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824001622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":24,"alternative-id":["S0049384824001622"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.05.009","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse of venous thromboembolism prophylaxis in hospitalized medical patients","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109036"}}